Fortress Biotech announces sale agreement

1. Fortress Biotech announces sale agreement Fortress bio is a biopharmaceutical company dedicated to acquire, develop and market new pharmaceutical and biotechnology products. Fortress develops and markets products both within Fortress and through certain subsidiary companies, also known as Fortress Companies. In addition to its internal development programs, Fortress leverages its expertise in biopharmaceutical business and its drug development capabilities and provides financing and administration services to help Fortress Companies achieve their goals. Fortress and Fortress Companies can seek licensing agreements, acquisitions, partnerships, joint ventures and / or public and private financing to accelerate and provide additional funds to support their research and development programs. For more information, visit https://en.wikipedia.org/wiki/Fortress_Biotech Fortress Biotech, Inc., a biopharmaceutical company dedicated to acquiring, developing and marketing new pharmaceutical and biotechnology products, today announced that it has signed an agreement to sell its 56.1 percent majority stake in National Holdings Corporation, a leading independent brokerage. in full services. Investment banking, commerce, insurance, accounting and asset management company, to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial, Inc., a diversified provider of financial and commercial advisory services. Under the terms of the agreement, National's 24.0 percent was sold at an initial closing on Friday, and the remaining 32.1 percent will be sold at the same price per share after FINRA's approval, for a total purchase price. Fortress Biotech Inc. is a biopharmaceutical company dedicated to acquire, develop and market new pharmaceutical and biotechnology products. Fortress plans to develop and market the products it acquires both directly and indirectly through the establishment of subsidiary companies, also known as Fortress Companies. The company will leverage its biopharmaceutical business experience and its drug development capabilities to help Fortress companies achieve their goals. In addition, the Company will provide financing and administration services to each of the Fortress Companies and, from time to time, the Company and Fortress Companies will seek licenses, partnerships, joint ventures and / or public and private financing to accelerate and provide additional funds to Support your research and development programs.